baber/WOPTO huggingface dataset:
Patent EP-1376892-A2 (EP)
Inventor: BARRATT CRAIG H
IPC: H04B17/00
Filed: 1999-04-22
Abstract: A partial spatial signature can be determined to be used in calibration. In one
embodiment, determining the partial spatial signature includes receiving a first segment of a
waveform, the first segment resulting from a radio transmitting a combined signal from a first
antenna element, the combined signal comprising the sum of a first signal and a second signal,
and calculating a first spatial signature related measurement using the received first segment, the
first signal and the second signal. The process may further include receiving a second segment of
the waveform, the second segment resulting from the radio transmitting the first signal from the
first antenna element, and the radio simultaneously transmitting the second signal from a second
antenna element, and calculating a second spatial signature related measurement using the second
received segment, the first signal, and the second signal. Then, determining the partial spatial
signature may be done using the first spatial signature related measurement and the second spatial
signature related measurement.
Patent EP-1421964-A2 (EP)
Inventor: PAJUNK HEINRICH
IPC: A61M5/32
Filed: 2003-11-06
Abstract: An ampoule holder for injection syringes, comprises a holder body (1) incorporating a chamber (4), and a protective cover slidable axially from a rest position to a safety position in which it fully covers the entire length of the injection needle.
Patent EP-1353214-A2 (EP)
Inventor: MI XIANG-DONG
IPC: G02B27/28
Filed: 2003-03-31
Abstract: Disclosed is a polarizer package comprising an integrated
combination of an absorbing layer and a compensator. Two of the identical
polarizer packages can be crossed and used in a transmissive optical device. This
polarizer package can also be used in combination with a reflective plate and a
quarter wave plate in a reflective optical device. Such polarizer packages exhibit
an improved viewing angle characteristic across all wavelengths of interest, has a
large tolerance for compensators to be aligned relative to their preferred
directions, and can be used within an LCD or emissive display system.
Patent EP-1369703-A2 (EP)
Inventor: ERKOCEVIC-PRIBIC RADMILA
IPC: G01S13/22
Filed: 2003-06-02
Abstract: This invention relates to radar signal processing. In particular, this
invention concerns Doppler processing and clutter filtering on irregular Pulse
Repetition Time (PRT) sampled signal. 
     This invention solves the above-mentioned drawbacks, in particular
solving the velocity ambiguity and filtering any type of clutter, providing a
deconvolution method which filter any kind of clutter even varying clutter like
sea clutter, rain clutter... 
     The deconvolution method of irregular pulse repetition time sampled
signal  x ( t m   ), comprises the following steps:
     [S1] conversion of the irregular samples  x ( t m   ) to regular samples  r ( iT ε   );   [S2] computation of the spectrum dft( r ) of these regular samples;   [S3] isolation of the clutter spectra in dft( r ) by assuming clutter spreads
over more than a few range gates;   [S4] estimation of the clutter spectral lines from the mean and the width of
the isolated clutter spectra;   [S5] subtraction of the estimated clutter spectra from the total spectrum
dft( r );   [S6] deconvolution of the remaining spectra.
Patent EP-1330035-A2 (EP)
Inventor: PATANA JARI PETRI
IPC: H03L7/197
Filed: 2003-01-17
Abstract: A fractional-N frequency synthesizer is disclosed wherein the multi-modulus
frequency divider in the feedback path of the phase locked loop is
controlled by a delta-sigma modulator to achieve the desired division ratio. The
fractional input control signal to the delta sigma modulator is dithered to break
any periodicity in the modulator output signal to avoid the generation of fractional
spurious frequencies.
Patent EP-1426711-A2 (EP)
Inventor: KIM YOON-YOUNG
IPC: F25D21/06
Filed: 2003-10-01
Abstract: The present invention relates to a cooling apparatus
including a compressor (102), a condenser (202), a first
expanding unit (204), a second expanding unit (206), a
third expanding unit (208), a first evaporator (106), and
a second evaporator (108); a first refrigerant circuit
containing refrigerant discharged from the compressor
(102) and flowing into a suction side of the compressor
(102) through the condenser (202), the first expanding
unit (204), the first evaporator (106), the second
expanding unit (206) and the second evaporator (108); a
second refrigerant circuit containing the refrigerant
passing through the condenser flowing into the suction
side of the compressor (202) through the third expanding
unit (208) and the second evaporator; a flow path control
unit (210) installed at a discharge side of the condenser
(202), switching a refrigerant flow path so that the
refrigerant passing through the condenser (202) flows
through at least one of the first and second refrigerant
circuits; and a control unit (302) selectively opening and
closing the flow path control unit (210). The invention
also relates to a method for controlling the apparatus.
Patent EP-1430870-A2 (EP)
Inventor: VAN NGUYEN NGHI
IPC: A61K8/00
Filed: 2003-12-19
Abstract: The present invention relates to hair compositions comprising at least one lecithin,
at least one amphoteric surfactant, at least one nonionic surfactant, at least one film
forming polymer, and at least one cationic polymer. The compositions are preferably used
to maintain hair's natural shape and/or its curl definition.
Patent EP-1490484-A2 (EP)
Inventor: LIOU JIING-REN
IPC: C12Q1/68
Filed: 2003-03-20
Abstract: L'invention concerne des réactifs régulant la kinase humaine inductible par BMP-2 et des réactifs se liant à des produits géniques de kinase humaine inductible par BMP-2, qui peuvent intervenir dans la prévention, l'amélioration ou la correction de dysfonctionnements et dans la prévention ou l'atténuation de maladies comprenant notamment, mais pas exclusivement, le cancer, le diabète, les troubles du système nerveux central, la bronchopneumopathie chronique obstructive, les troubles gastro-intestinaux et les troubles cardio-vasculaires.
Patent EP-1474255-A2 (EP)
Inventor: REMY JEAN-BAPTISTE
IPC: B21C51/00
Filed: 2003-02-14
Abstract: The invention relates to a method for marking and identifying linear elements such as steel reinforcements (F) for concrete, characterised in that said method comprises marking said steel reinforcements by controlling movement and at least one projection of at least one mobile marking head (200) in co-operation with the movement of said steel reinforcements (F). The invention further relates to devices for carrying out said method and a computer product for managing the same.
Patent EP-1519744-A2 (EP)
Inventor: LI REBECCA H
IPC: A61K47/36
Filed: 2003-05-12
Abstract: Composition injectable ou implantable sous forme de tige pour l'administration de protéine ostéogènes. Ladite composition contient des dérivés d'acide hyaluronique et des protéines ostéogènes, et éventuellement des excipients et des principes actifs tels qu'un inhibiteur de la résorption osseuse. Des procédés de préparation desdites compositions pharmaceutiques injectables en forme de tige et des procédés d'utilisation desdites compositions ostéogènes pour traiter les os ostéoporotiques et / ou ostéopéniques sont également décrits.
Patent EP-1506008-A2 (EP)
Title: Vaccins muqueux avec adjuvant de chitosane et/ou antigenes meningococciques
Inventor: DEL GIUDICE GIUSEPPE
IPC: A61P31/04
Filed: 2003-05-14
Abstract: La présente invention concerne des compositions immunogènes comprenant (a) un antigène saccharide capsulaire du sérogroupe C de N.meningitidis, et (b) un adjuvant de chitosane. Cette composition comprend, de préférence, (c) un ou plusieurs antigènes et/ou (d) un au plusieurs autres adjuvants. Ces compositions conviennent particulièrement pour un apport muqueux, notamment un apport intranasal. Cette invention concerne aussi des compositions immunogènes destinées à un apport muqueux comprenant des saccharides capsulaires d'au moins deux des sérogroupes A, C, W135 et Y de N.meningitidis. Il est préférable que les saccharides capsulaires présents dans les compositions de cette invention soient conjugués avec une ou des protéines porteuses et/ou qu'elles soient des oligosaccharides. Des antigènes oligosaccharides conjugués sont particulièrement préférés.
Patent EP-1525216-A2 (EP)
Title: Therapie combinee pour le traitement d'infection vih
Inventor: BUELOW ROLAND
IPC: A61K38/08
Filed: 2003-01-24
Abstract: La présente invention a trait à des préparations pharmaceutiques et des procédés permettant le traitement de sujets atteints du virus de l'immunodéficience humain (VIH). Les préparations pharmaceutiques comprennent un agent immunorégulateur et un composé antirétroviral. Les préparations pharmaceutiques sont utilisées pour le traitement de patients atteints de VIH, notamment pour les complications gastro-intestinales résultant d'une infection virale. En outre, les préparations pharmaceutiques de la présente invention ont pour effet d'élever les niveaux des lymphocytes T CD4+ positifs simples et de CD4+ et CD8+ positifs doubles, favorisant ainsi la restauration et la normalisation du système immunitaire suite à une infection de VIH.
Patent EP-1490106-A2 (EP)
Inventor: GUZMAN CARLOS ALBERTO
IPC: A61K39/39
Filed: 2003-04-03
Abstract: The use of lipopeptides or lipoproteins (I), designated macrophage activating lipopeptides (MALP), as a mucosal adjuvant for therapeutic or prophylactic vaccination viathe mucosa is new. Also claimed is the use of (I) (with some specific compounds excepted) as adjuvants for non-mucosal vaccination. The use of a lipopeptide or lipoprotein of formula (I) is claimed as a mucosal adjuvant for therapeutic or prophylactic vaccination viathe mucosa. [Image] R 1, R 27-25C alkyl, 7-25C alkenyl or 7-25C alkynyl; X : S, O or CH 2; R 3, R 4H or Me; and Y : sequence of 1-25 (preferably 12-25) amino acid residues, which is physiologically acceptable and not in itself immunogenic in the species to be treated; provided that the asterisked C atom has absolute R-configuration if X = S. An independent claim is also included for the use of (I) as adjuvant for non-mucosal vaccination, with the additional proviso that (I) is other than an S-(2,3-diacyloxypropyl)-cysteine peptide (I') of the sequence Asp-hcGly-Asn-Asn-Asp-Glu-Ser-Asn-Ile-Glu-Ser-Phe-Glu-Lys-Glu-Lys, where the amino acids in position 2 and optionally 3 at the N-terminal are optionally absent and/or 1 or 2 aminoacids may be deleted from the C-terminal. ACTIVITY : Immunostimulant. Mice were immunized intranasally on days 0, 7 and 14 with 40 mu g beta -galactosidase (as model antigen) or a mixture of 40 Microg beta -galactosidase and 1 Microg MALP-2 (Ia) as adjuvant. On day 28 serum samples were analyzed by enzyme-labeled immunosorbent assay for the beta -galactosidase-specific antibody titer. The titers, in absorption value units (OD 405 nm), were 0.25 in the absence of (Ia) and 0.30 in presence of (Ia). MECHANISM OF ACTION : None given.
Patent EP-1590499-A2 (EP)
Title: Procede ameliore de plaquage de l'argent, et articles ainsi realises
Inventor: CHANDRA SATISH N
IPC: C23C18/44
Filed: 2003-09-19
Abstract: L'invention porte sur un procédé amélioré de plaquage d'argent sur un substrat organique utilisant en partie du Na4EDTA qui facilite la formation de grains et la récupération de l'argent présent dans des déchets. L'invention porte également sur des articles réalisés à l'aide dudit procédé.
Patent EP-1565231-A2 (EP)
Title: Diagnostics de pompes rotatives a sang et controleur de debit cardiaque
Inventor: BEARNSON GILL
IPC: A61M1/12
Filed: 2003-08-21
Abstract: L'invention concerne un procédé et un appareil permettant de contrôler un dispositif d'assistance ventriculaire. Ce procédé consiste à prendre un dispositif d'assistance ventriculaire (12) pouvant être défini en termes de paramètres opérationnels tels que la vitesse de la pompe ou le courant ; à mesurer (160) au moins un paramètre physiologique reflétant un état physiologique correspondant à un patient ; à mettre en corrélation (162) au moins un paramètre physiologique mesuré du patient avec au moins un paramètre opérationnel à l'aide d'un procédé d'évaluation ; à sélectionner (92) un état physiologique définissable par les valeurs souhaitées des paramètres physiologiques ; à surveiller (158) au moins un paramètre opérationnel et à contrôler les valeurs d'entrée (102) du paramètre opérationnel sur la base du résultat obtenu à l'étape de surveillance. L'appareil (10) comprend une pompe (106) entraînée par un moteur premier (26) et ayant une hélice (24). Un détecteur (32) détecte la valeur d'un paramètre opérationnel de la pompe (106). Un processeur (30) fournit une corrélation statistique entre les paramètres physiologiques des patients et les paramètres opérationnels de la pompe (106) et ajuste les paramètres opérationnels obtenir un état physiologique optimal prédéterminé.
Patent EP-1547423-A2 (EP)
Inventor: SCHMITT HARALD
IPC: H04W8/18
Filed: 2003-09-29
Abstract: The invention relates to a method for the provision of operator-specific performance features of different mobile radio network operators for a mobile radio customer, whereby the mobile radio customer has a smart card, on which a user relationship for the mobile radio customer with a mobile radio network operator is stored. The method is characterized in that at least two user relationships are defined on the smart card of the mobile radio customer with differing mobile radio call numbers and with independent performance features and a mobile radio network operator is assigned to each user relationship.
Patent EP-1572043-A2 (EP)
Inventor: EGILSSON EGILL SVEINBJORN
IPC: A61F2/50
Filed: 2003-12-17
Abstract: La présente invention concerne un manchon doublure de suspension qui sert d'interface entre un membre résiduel et une emboîture de prothèse dure. Cette doublure comprend un joint élastique s'étendant autour de sa périphérie extérieure de façon à renforcer un effet d'étanchéité entre ce manchon et l'intérieur d'une emboîture de prothèse afin d'isoler l'extrémité distale de cette emboîture de l'atmosphère et améliorer ainsi la retenue de ce manchon doublure et du membre résiduelle dans cette emboîture de prothèse.
Patent EP-1532444-A2 (EP)
Inventor: GIESING MICHAEL
IPC: C12Q1/68
Filed: 2003-08-20
Abstract: L'invention concerne une méthode permettant d'analyser des liquides organiques, pour rechercher d'éventuelles cellules cancéreuses, son utilisation et des kits d'analyse correspondants, ainsi que les possibilités de traitement du cancer qui en découlent. Ladite méthode se fonde sensiblement sur la détermination de l'expression du gène de mangano-superoxyde-dismutase, de thiorédoxine-réductase et/ou d'une glutathionperoxydase. L'utilisation de cette méthode permet notamment d'effectuer un diagnostic et un pronostic tumoral plus sûrs. La réduction d'une expression plus grande de ces gènes revêt une importance thérapeutique et peut s'utiliser dans le traitement du cancer.
Patent EP-1728358-A2 (EP)
Inventor: BODUCH MARK E
IPC: H04L12/56
Filed: 2003-10-31
Abstract: Systems and methods for cell based wrapped wave front arbiter (WWFA) with bandwidth reservation are disclosed. The method for reserving bandwidth of a given priority using the WWFA for arbitrating bandwidth among virtual links between input and output ports, each virtual link supporting one or more priorities and corresponding to an arbitration unit (AU) of the WWFA generally comprises performing at least one arbitration pass of a wave front of the WWFA where AUs having a reserved bandwidth request of a given priority and reserved bandwidth credit of the given priority compete for the bandwidth associated with the wave front, and where AUs not having a reserved bandwidth request of the given priority and reserved bandwidth credit of the given priority do not compete for the bandwidth, and performing at least one subsequent arbitration pass where AUs having a reserved bandwidth request of the given priority compete for the bandwidth.
Patent EP-1452941-A2 (EP)
Inventor: NARIN ATTILA
IPC: G06Q30/00
Filed: 2004-01-29
Abstract: A licensor receives a request from a requestor including an identifier
identifying the requestor and rights data associated with digital content, where the
rights data lists at least one identifier and rights associated therewith. The
licensor thereafter locates the identifier of the requestor in a directory, and locates
in the directory based thereon an identifier of each group which the requestor is a
member of. Each of the located requestor identifier and each located group
identifier is compared to each identifier listed in the rights data to find a match, and
a digital license to render the content is issued to the requestor with the rights
associated with the matching identifier.
Patent EP-1467396-A2 (EP)
Inventor: KOMAKI TOSHIHIRO
IPC: H01J17/49
Filed: 2004-04-08
Abstract: A front glass substrate is opposite a back substrate with a
discharge space in between. On the rear-facing face of the front
glass substrate are provided a plurality of row electrode pairs (X1,Y1)
each extending in the row direction and regularly arranged in the
column direction to individually form display lines; and a plurality
of column electrodes (D1) each extending in a direction at right angles
to the row electrode pairs (X1,Y1) and separated from the row electrode
pair (X1,Y1) by a first dielectric layer. A partition wall partitions the
discharge space into discharge cells each opposite the opposed
transparent electrodes of the row electrode pair (X1,Y1). In the plasma
display panel structured in this manner, the back substrate is
constituted of a metal plate having the surface covered with an
insulation layer.
Patent EP-1493858-A2 (EP)
Inventor: TAKATA AKIRA
IPC: D02H5/02
Filed: 2004-06-25
Abstract: A warp sizing method performs pretreatment to adhere the
pretreatment liquid (36) to a plurality of warps (12) arranged in a
sheet-like form and squeeze, and divides the pretreated plural warps (12)
into a plurality of warp groups (38, 40) to adhere a sizing liquid (42) to each
of the divided warp groups (38, 40). A dividing treatment includes
bringing the warps (12) of the warp group (38, 40) to be divided into contact
with a guide roller (80, 82) of each warp group (38, 40). A pretreatment
liquid (36) contains a sizing liquid (42) having the same or less size
concentration as or than that of the sizing liquid (42) to be used in the
sizing treatment or water.
Patent EP-1484699-A2 (EP)
Inventor: BENTZIEN JOERG
IPC: G16B30/20
Filed: 2002-08-12
Abstract: The invention relates to the use of protein design automation (PDA™) to
generate computationally prescreened secondary libraries of proteins, and to methods
and compositions utilizing the libraries.
Patent EP-1512833-A2 (EP)
Inventor: KRAEMER JOHANN DR
IPC: F04D29/28
Filed: 2004-07-30
Abstract: The rotor has a reinforced core structure (4) and an external functional sector. The core structure is produced by pushing concentric reinforcement shells (8) one over the other. The length (10) of the shell varies. The functional sector is cast onto the core structure. The length of each shell decreases as the external diameter increases.
Patent EP-1533308-A2 (EP)
Title: A process for producing a simvastatin precursor
Inventor: TAOKA NAOAKI
IPC: C07D309/30
Filed: 1999-12-10
Abstract: This invention provides an easy and efficient process for producing a simvastatin
of great use as an HMG-CoA reductase inhibitor, 
   which comprises deacylation of lovastatin with an inorganic base and a secondary
or tertiary alcohol and subjecting the resulting did lactone to selective protection with a
ketal or acetal protective group, acylation and deprotection-lactonization to give
simvastatin.
Patent EP-1518877-A2 (EP)
Inventor: SPRAYBERRY HAROLD BLAKE
IPC: C08G63/183
Filed: 1998-07-24
Abstract: The present application relates to a large molded polyester container
weighing greater than about 200, and preferably between about 200 and about
800 grams. Specifically, the present application relates to polyester containers
having a volume of several gallons. The container is a bottle formed from a
PET polyester containing from 3.5 mol % to 20 mol % copolymer modification
wherein said polyester possesses an IV of about 0.75 to about 0.85.
Patent EP-1442879-A2 (EP)
Inventor: SCHAEDE JOHANNES
IPC: B41F13/21
Filed: 2000-01-18
Abstract: The cylinder drive includes two cylinders (01, 02) with friction gears (06, 07). The ratio of the radius (r06) of the friction gear of the first cylinder to a whole-number multiple of the radius (r07) of the friction gear of the second cylinder is less than 1.02 and greater than 1.0005. By this means, the friction torque produced by the process-related friction gear (03, 04) is approximately compensated by the additional friction torque of the second friction gear.
Patent EP-1519169-A2 (EP)
Inventor: PETERSON STEVEN H
IPC: G01J3/50
Filed: 2004-09-22
Abstract: An LED-based color measurement instrument including an illumination system
and a sensing system. The illumination system includes modulated LEDs and a temperature
control system for regulating the temperature of the LEDs, thereby improving the consistency of
their performance. The sensing system includes a photodiode, a transimpedance amplifier, and
an integrator in the first stage to cancel the effect of ambient light on the output of the first stage.
The sensing system also includes a lens system for imaging a target area of the target sample
onto the photo sensor in a manner so that the product of the target area times the solid angle
captured by the lens system is generally uniform over a selected range of distances, thereby
reducing the positional sensitivity of the instrument with respect to the target sample.
Patent EP-1467456-A2 (EP)
Inventor: PINI BELISARIO
IPC: F21S8/06
Filed: 2004-03-17
Abstract: Cable-retainer apparatus comprising two elements (1,
2) cooperating with each other for locking one or more
electric cables (3), characterized in that the said
elements (1, 2) delimit two longitudinal inner
passages (10) for the electric cables (3) and a seat
(4) for anchoring the head section (50) of a cord or
tension rod (5) intended for suspending a chandelier
or a lamp (6).
Patent EP-1590736-A2 (EP)
Inventor: STAMOS NICHOLAS
IPC: H04L12/26
Filed: 2004-01-21
Abstract: L'invention concerne une technique pour effectuer un contrôle d'utilisation sur des biens numériques, notamment sur des fichiers informatiques. Le modèle de système permet non seulement de tracer l'accès à des fichiers par des utilisateurs autorisés, mais également de surveiller le passage de tels fichiers sur un support de stockage amovible non contrôlable ou dans des connexions de réseau et analogues, ce qui peut indiquer des abus possibles de droits d'accès. Selon un mode de réalisation préféré de l'invention, un processus d'agent indépendant autonome s'exécutant à un point d'utilisation, notamment un processus de fond d'un noyau du système d'exploitation client, permet d'interrompre des demandes d'accès à des ressources. Le processus agent détecte des événements de système de faible niveau, les filtres, et forme des agrégats avec ceux-ci. Un moteur de règles analyse des séquences d'événements d'agrégats pour déterminer l'apparition de violation de règles.